MINK THERAPEUTICS INC (INKT)
US6036931029 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to INKT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 692.23% above the current price.
INKT was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about INKT.
In the previous month the buy percentage consensus was at a similar level.
INKT was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-22 | Evercore ISI Group | Maintains | Outperform |
| 2023-03-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-10 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-11-09 | William Blair | Initiate | Outperform |
| 2021-11-09 | Evercore ISI Group | Initiate | Outperform |
| 2021-11-09 | Baird | Initiate | Outperform |